Cardiovascular devices and platelet interactions: understanding the role of injury, flow, and cellular responses.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed.

1. Thrombocytopenia Complicating Transcatheter Aortic Valve Implantation: Differences Between Two New-Generation Devices.Journal of cardiovascular translational research · 2021
   Article
2. Anticoagulant independent mechanical heart valves: viable now or still a distant holy grail.Annals of translational medicine · 2016
   Article
3. Novel mediators and biomarkers of thrombosis.Journal of thrombosis and thrombolysis · 2014
   Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

13 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as